Published 2 days ago • loading... • Updated 12 hours ago

Senolytics offer hope for more precise Alzheimer's treatments

Summary by News Medical

A new research paper was published in Aging (Aging-US) on March 29, 2025, as the cover of Volume 17, Issue 3, titled "Differential senolytic inhibition of normal versus Aβ-associated cholinesterases: implications in aging and Alzheimer's disease."

7 Articles

All

Left

Center

Right

Digital Trends

Center

VR isn’t just fun. It’s a new hope for early detection of Alzheimer’s

Researchers see VR spaces as a test for spatial memory in people, hoping to look for signs of cognitive decline that are an early sign of Alzheimer’s disease.

2 days ago·United States

Read Full Article

News Medical

Center

Senolytics offer hope for more precise Alzheimer's treatments

2 days ago·United States

Read Full Article

Scienmag: Latest Science and Health News

Temple University Researchers Uncover Novel Targeted Strategy to Shield

In the realm of neurodegenerative diseases, scientists continue to unravel the intricacies of cellular mechanisms that lead to conditions such as Alzheimer’s and Parkinson’s disease. Central to these processes is an enzyme known as dual leucine-zipper kinase (DLK), which plays a detrimental role in the progression of neuronal degeneration. This enzyme acts as a signaling agent, activating the self-destruction process in neurons that have been da…

12 hours ago

Read Full Article

European Medical Journal

Moderate Alcohol Consumption Linked to Alzheimer's Biomarkers in New Study

A new study finds that even light-to-moderate alcohol consumption may be linked to increased amyloid beta deposition, a key biomarker of Alzheimer’s disease.

14 hours ago

Read Full Article

Clinical Trials Arena

AD/PD 2025: Alzheon’s ALZ-801 shows promise for MCI but missed in mild Alzheimer’s

At the AD/PD 2025 International Conference, Alzheon presented data from its Phase III trial of ALZ-801 for early Alzheimer’s disease.The post AD/PD 2025: Alzheon’s ALZ-801 shows promise for MCI but missed in mild Alzheimer’s appeared first on Clinical Trials Arena.

1 day ago

Read Full Article

Labiotech.eu

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Delve into how the biotech industry is pivoting from the amyloid hypothesis to find new Alzheimer's disease treatments. The post Beyond amyloid: The search for the next big thing in Alzheimer’s treatment appeared first on Labiotech.eu. © Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and links may be u…

2 days ago

Read Full Article

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year